|
| Exchange Disseminated Time | Neuland Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 09, 2014, inter-alia to consider and take on record the audited financial results of the Company for the year ended March 31, 2014 and to consider and recommend dividend, if any.
Further the Company has informed that, as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from April 24, 2014 to May 12, 2014 (both days inclusive), inter alia, for the purpose of announcement of the audited Financial Results by the Company. |
|
|